HSBC Holdings’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172K Sell
250,172
-45,228
-15% -$42.2K ﹤0.01% 2646
2025
Q4
$464K Buy
295,400
+26,996
+10% +$43.1K ﹤0.01% 2355
2025
Q3
$408K Sell
268,404
-4,814
-2% -$8.37K ﹤0.01% 2199
2025
Q2
$598K Buy
273,218
+219,662
+410% +$532K ﹤0.01% 2058
2025
Q1
$144K Buy
53,556
+4,765
+10% +$18.8K ﹤0.01% 2713
2024
Q4
$199K Buy
48,791
+16,554
+51% +$62.6K ﹤0.01% 2722
2024
Q3
$126K Buy
32,237
+13,707
+74% +$57.8K ﹤0.01% 2754
2024
Q2
$74.8K Sell
18,530
-17,086
-48% -$73.5K ﹤0.01% 2781
2024
Q1
$153K Buy
35,616
+8,081
+29% +$37.9K ﹤0.01% 2756
2023
Q4
$124K Sell
27,535
-5,046
-15% -$19.6K ﹤0.01% 2561
2023
Q3
$101K Sell
32,581
-7,773
-19% -$31.2K ﹤0.01% 2544
2023
Q2
$180K Sell
40,354
-154,875
-79% -$712K ﹤0.01% 2344
2023
Q1
$944K Buy
195,229
+82,162
+73% +$405K ﹤0.01% 1782
2022
Q4
$608K Sell
113,067
-27,650
-20% -$170K ﹤0.01% 2200
2022
Q3
$910K Sell
140,717
-12,142
-8% -$67.7K ﹤0.01% 1878
2022
Q2
$708K Buy
152,859
+1,918
+1% +$9.45K ﹤0.01% 2118
2022
Q1
$1.06M Buy
150,941
+42,085
+39% +$287K ﹤0.01% 1906
2021
Q4
$1.11M Buy
108,856
+5,706
+6% +$61.3K ﹤0.01% 1984
2021
Q3
$1.25M Buy
+103,150
New +$1.56M ﹤0.01% 1760

Other funds holding MXCT

HSBC Holdings's MXCT Position: Q1 2026 in Review

HSBC Holdings reduced its MaxCyte (MXCT) stake by 15% in Q1 2026, selling an estimated $42.2K and leaving 250,172 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

HSBC Holdings first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.25M in Q3 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • HSBC Holdings held 250,172 shares of MaxCyte worth $172K as of Q1 2026.
  • HSBC Holdings sold 45,228 MaxCyte shares in Q1 2026, an estimated $42.2K.
  • MaxCyte made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2646 holding.
  • HSBC Holdings first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • HSBC Holdings's MaxCyte position peaked at $1.25M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.